Search Results 801-810 of 18417 for prednisone

1. A Study of Cemiplimab in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy - Mayo Clinic

   Immunosuppressive corticosteroid doses (>10mg prednisone) within 28 days prior to treatment with Cemiplimab; Active infections requiring therapy, including ...

2. A Study to Evaluate Inflammation of the Heart Muscle Tissue in Patients with Rheumatoid Arthritis - Mayo Clinic

   Prednisone > 10mg per day (or equivalent corticosteroid dose per day within last week). Irregular heart rhythm (arrhythmia or cardiac conduction abnormality ...

3. Phase III Study of DCVAC Added to Standard Chemotherapy for Men with Metastatic Castration Resistant Prostate Cancer - Mayo Clinic

   Subjects who are not indicated for chemotherapy treatment with first line Standard of Care chemotherapy (docetaxel and prednisone); Systemic corticosteroids ...

4. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study - Mayo Clinic

   nivolumab/cabozantinib treatment. - Participants must not have active autoimmune disease requiring systemic steroids (equivalent of > 10mg of prednisone) or ...

5. Study to Evaluate Safety and Preliminary Efficacy of MOR208 With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi (COSMOS) - Mayo Clinic

   Systemic corticosteroids in doses greater than prednisone equivalent to 20 mg/day with the exception of patients with signs of rapidly progressing disease ...

6. Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

   Oral corticosteroid therapy (prednisone or equivalent steroid at a dose less than or equal to [<=] 50 milligram per day [mg/day], budesonide at a dose <= 9 mg/ ...

7. Abdominal pain - Mayo Clinic

   Prednisone withdrawal: Why taper down slowly? ... Salt craving: A symptom of Addison's disease? ... Spastic colon: What does it mean? ... STD testing: What's right ...

8. Giant Cell Arteritis Vessel Wall Enhancement - Mayo Clinic

   Participant must be within 14 days of initiating or escalating systemic glucocorticoids (e.g., prednisone) OR have ongoing cranial symptoms concerning for ...

9. Study of INCB053914 in Subjects With Advanced Malignancies - Mayo Clinic

   The following are allowed: hydroxyurea for controlling proliferative disease and low-dose corticosteroids (prednisone or equivalent ≤ 10 mg per day).

10. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects - Mayo Clinic

    ... prednisone within 30 days before the first dose of study treatment on W1D1: Subjects who are currently receiving steroids at a prednisone-equivalent dose of ...